1) Pregnancy places significant demands on the cardiovascular system due to increases in blood volume, cardiac output, heart rate and changes in blood pressure and chemistry.
2) Women with preexisting heart conditions like rheumatic heart disease may experience worsening symptoms during pregnancy due to these demands. Care during pregnancy involves monitoring, activity restriction, medication and potential termination if risk is too high.
3) Delivery requires close supervision by obstetricians and cardiologists due to risks of heart failure from labor and postpartum blood loss. Overall maternal mortality is low for mild conditions but can be over 7% for severe illnesses if not properly managed.
Here are a few key things we can do:
1. Provide thorough preconception counseling to assess risk and optimize medical condition before pregnancy if possible.
2. Ensure careful multidisciplinary antenatal care involving cardiologists, obstetricians, anesthesiologists to monitor for complications.
3. Plan delivery carefully considering hemodynamic changes, with options for early delivery or C-section if needed.
4. Be vigilant for dangerous periods like labor/delivery when changes in volume and pressure occur abruptly. Have low threshold for ICU admission.
5. Educate patients and families on warning signs and ensure close postpartum follow up as this is a high risk period.
6.
This document discusses cardiac diseases in pregnancy, including normal pregnancy physiology, symptoms of cardiac disease, preconception counseling, contraindications to pregnancy for certain heart conditions, genetic inheritance of cardiac conditions, and management of specific diseases. It covers topics like dilated cardiomyopathy, peripartum cardiomyopathy, congenital heart diseases involving left-to-right shunts or obstructive lesions, rheumatic heart disease including mitral stenosis, mitral valve prolapse, and Marfan syndrome. Pregnancy risks and management approaches are described for each condition. A team-based approach involving multiple specialists is recommended.
This document discusses the approach to cardiac disease in pregnancy. It begins by outlining the normal physiological changes in pregnancy that place additional strain on the cardiovascular system. It then describes a systematic approach to evaluating and monitoring different types of cardiac lesions during pregnancy based on how well they are tolerated by the increased cardiovascular demands. High-risk cardiac conditions that require close monitoring and individualized treatment plans are also outlined.
This document discusses guidelines for the treatment of heart disease in pregnancy. It covers topics like pre-conception counseling, cardiovascular drug therapy in pregnancy, contraceptive methods for women with heart disease, and future perspectives. The guidelines recommend counseling women with cardiac conditions who want to get pregnant. They also provide guidance on the use of specific drugs in pregnancy like aspirin, amiodarone, ACE inhibitors, beta blockers, and discuss alternatives to warfarin. Management strategies are discussed for various heart conditions according to guidelines from ACC/AHA.
1. Pregnancy places significant demands on the cardiovascular system due to increases in blood volume, cardiac output, and heart rate.
2. Common cardiac problems during pregnancy include congenital heart defects, heart failure, and pulmonary hypertension. These conditions can lead to complications for both mother and baby if not properly managed.
3. Testing such as echocardiography and stress testing are used to evaluate cardiac function during pregnancy. Treatment depends on the severity and type of condition, with termination of pregnancy recommended for very high risk cases.
Here are a few key things we can do:
1. Provide thorough preconception counseling to assess risk and optimize medical condition before pregnancy if possible.
2. Ensure careful multidisciplinary antenatal care involving cardiologists, obstetricians, anesthesiologists to monitor for complications.
3. Plan delivery carefully considering hemodynamic changes, with options for early delivery or C-section if needed.
4. Be vigilant for dangerous periods like labor/delivery when changes in volume and pressure occur abruptly. Have low threshold for ICU admission.
5. Educate patients and families on warning signs and ensure close postpartum follow up as this is a high risk period.
6.
This document discusses cardiac diseases in pregnancy, including normal pregnancy physiology, symptoms of cardiac disease, preconception counseling, contraindications to pregnancy for certain heart conditions, genetic inheritance of cardiac conditions, and management of specific diseases. It covers topics like dilated cardiomyopathy, peripartum cardiomyopathy, congenital heart diseases involving left-to-right shunts or obstructive lesions, rheumatic heart disease including mitral stenosis, mitral valve prolapse, and Marfan syndrome. Pregnancy risks and management approaches are described for each condition. A team-based approach involving multiple specialists is recommended.
This document discusses the approach to cardiac disease in pregnancy. It begins by outlining the normal physiological changes in pregnancy that place additional strain on the cardiovascular system. It then describes a systematic approach to evaluating and monitoring different types of cardiac lesions during pregnancy based on how well they are tolerated by the increased cardiovascular demands. High-risk cardiac conditions that require close monitoring and individualized treatment plans are also outlined.
This document discusses guidelines for the treatment of heart disease in pregnancy. It covers topics like pre-conception counseling, cardiovascular drug therapy in pregnancy, contraceptive methods for women with heart disease, and future perspectives. The guidelines recommend counseling women with cardiac conditions who want to get pregnant. They also provide guidance on the use of specific drugs in pregnancy like aspirin, amiodarone, ACE inhibitors, beta blockers, and discuss alternatives to warfarin. Management strategies are discussed for various heart conditions according to guidelines from ACC/AHA.
1. Pregnancy places significant demands on the cardiovascular system due to increases in blood volume, cardiac output, and heart rate.
2. Common cardiac problems during pregnancy include congenital heart defects, heart failure, and pulmonary hypertension. These conditions can lead to complications for both mother and baby if not properly managed.
3. Testing such as echocardiography and stress testing are used to evaluate cardiac function during pregnancy. Treatment depends on the severity and type of condition, with termination of pregnancy recommended for very high risk cases.
Cardiac disease is a leading cause of maternal mortality. During pregnancy, the cardiac output increases by 40% which can worsen existing heart conditions like rheumatic heart disease. Rheumatic heart disease, caused by untreated streptococcal infections, accounts for 90% of heart conditions in pregnancy. It often involves mitral stenosis which carries risks of heart failure, infection, blood clots and fetal loss. Pregnancy also poses risks for other heart conditions like congenital heart defects. Care involves a multidisciplinary approach with cardiologists, focusing on monitoring, limiting activity and weight gain, avoiding anemia and fluid overload to reduce stress on the heart. Vaginal delivery is preferred when possible but C-sections may be needed
This document discusses heart disease in pregnancy. It notes that rheumatic valvular heart disease is the most common cause of cardiovascular disease in pregnancy in developing countries. The most common rheumatic lesion is mitral stenosis. Congenital heart disease is the most frequent cardiovascular disease present during pregnancy in industrialized countries, with shunt lesions being predominant. Pregnancy can exacerbate pre-existing heart conditions and lead to complications like heart failure, arrhythmias, and pulmonary edema due to the increased cardiovascular demands. Careful management and monitoring during pregnancy and delivery are important for women with heart disease.
Hypertensive disorders in pregnancy are classified into four main categories: gestational hypertension, preeclampsia, chronic hypertension, and chronic hypertension with superimposed preeclampsia. Preeclampsia is defined as new onset hypertension and proteinuria after 20 weeks of gestation. It is caused by abnormal placentation leading to maternal endothelial dysfunction and is a leading cause of maternal and fetal morbidity and mortality. Risk factors include obesity, family history, and chronic hypertension. Treatment involves frequent monitoring, antihypertensive medications like labetalol, methyldopa, and nifedipine, and delivery if condition worsens or reaches term.
This document discusses heart disease in pregnancy. It notes that 0.4-5.0% of pregnant women have heart disease, which is a leading cause of maternal mortality. The most common heart disorders seen in pregnancy are rheumatic valve disease, congenital heart disease, and cardiomyopathy. Physiological changes in pregnancy like increased blood volume, cardiac output, and heart rate are described. Guidelines for assessing risk, managing specific conditions, determining delivery timing/location, and optimizing outcomes for mothers and babies with heart disease are provided. The importance of pre-conception counseling and a multidisciplinary approach to care is emphasized.
This document discusses cardiac disease in pregnancy. The major causes of cardiac death over the last 10 years are cardiomyopathy, myocardial infarction, and ischemic heart disease. Physiological adaptations to pregnancy include increases in blood volume, stroke volume, heart rate, and cardiac output. Labor further increases cardiac output. Examination may reveal murmurs. Echocardiography is the preferred investigation. Risks are assessed based on factors like pulmonary hypertension and cardiac function. Management involves a multidisciplinary team and monitoring for decompensation. Risks vary for different cardiac lesions and are managed accordingly, such as with endocarditis prophylaxis.
The document discusses various types of heart diseases that can occur during pregnancy including rheumatic heart disease and congenital heart disease. It notes that the two main types of rheumatic heart disease are mitral stenosis and rheumatic fever. Mitral stenosis is the most common, affecting 90% of cases. Congenital heart diseases discussed include atrial septal defects, ventricular septal defects, and patent ductus arteriosus. Complications related to heart disease in pregnancy and their treatment are summarized. Maternal and fetal risks are also categorized as low, moderate, or high risk.
Cardiovascular diseases during pregnancy, european guidlines 2011Basem Enany
This document discusses cardiac signs, symptoms, and management during pregnancy. Some normal signs include palpitations, edema, and dizziness due to increased blood volume and heart rate. Abnormal signs like anasarca and syncope require evaluation. Testing like echocardiograms are generally safe in pregnancy but radiation exposure should be minimized. Conditions like pulmonary hypertension carry high risks, while repaired defects usually pose little risk. Medical management of valvular issues and heart failure aims to support volume and avoid hypotension.
This document discusses the cardiovascular changes that occur during pregnancy and how they impact women with underlying heart disease. It notes that the incidence of heart disease complicating pregnancy is approximately 1% globally. The most common types seen in India are rheumatic heart disease (78%) and congenital heart disease (18.7%). The document outlines the normal anatomical and physiological changes pregnancy has on the cardiovascular system. It then discusses how certain heart conditions are classified based on their risk during pregnancy, from WHO class 1 (lowest risk) to WHO class 4 (highest risk). The document provides guidance on evaluating and managing women with heart disease throughout their pregnancy.
The document discusses HELLP syndrome, which is characterized by hemolysis, elevated liver enzymes, and low platelet count. It is considered by some to be a variant of preeclampsia, but may be a separate entity. HELLP syndrome has a maternal mortality rate of 2-24% and perinatal mortality of 9-39%. Diagnosis requires meeting laboratory criteria of hemolysis, elevated liver enzymes, and low platelet count. Management includes corticosteroids, magnesium sulfate, antihypertensive drugs, blood products, and delivery. Complications include disseminated intravascular coagulation, liver and kidney failure, and infant growth restriction and respiratory distress.
Peripartum cardiomyopathy is a form of heart failure that develops in the final month of pregnancy or within 5 months after delivery. It is defined as left ventricular systolic dysfunction without other identifiable causes. Risk factors include age over 30, multiparity, African descent, cocaine use, long term tocolytic therapy, multiple gestation, preeclampsia history, and nutritional deficiencies. Diagnosis involves excluding other causes by EKG, echocardiogram, labs, and symptoms matching criteria. Treatment is similar to other heart failures with diuretics, beta-blockers, digoxin, and anticoagulants considering pregnancy risk classifications. Prognosis shows 50-60% recovery within 6 months but high
Pregnancy places an additional burden on the heart due to significant hemodynamic changes. The incidence of heart disease during pregnancy has increased due to more women with congenital heart disease surviving to reproductive age. Hemodynamic changes during pregnancy and labor like increased blood volume, heart rate and cardiac output can exaggerate the symptoms of heart conditions. Close monitoring and management of heart conditions and risks is needed before, during and after pregnancy to support a healthy pregnancy outcome.
Maternal collapse during pregnancy and puerperiumDoc Nadia
The document discusses maternal collapse during pregnancy and postpartum. It defines maternal collapse and identifies women at risk. Common causes include hemorrhage, thromboembolism, amniotic fluid embolism, cardiac disease, sepsis, and other medical conditions. The initial management of maternal collapse follows resuscitation guidelines, securing the airway, providing oxygen, performing chest compressions if needed, and administering IV fluids and medications. If collapse occurs after 20 weeks gestation and there is no response to 4 minutes of CPR, perimortem cesarean delivery should be performed within 5 minutes to help maternal resuscitation efforts.
Maternal collapse by dr alka mukherjee &; dr apurva mukherjeealka mukherjee
Not all maternal deaths are preceded by an identifiable collapse, and not all maternal collapses result in death. Maternal collapse occurs any time during pregnancy, up to 42 days following delivery and is an acute event involving cardiorespiratory systems and/or brain, resulting in impaired consciousness or death.1
Maternal deaths are generally quantified as a maternal mortality ratio (MMR), expressed as the number of maternal deaths per 100,000 women giving birth. It includes deaths that occur due to complications of the pregnancy (direct deaths), and those resulting from worsening of other disease processes due to the pregnancy (indirect deaths). Deaths that occur from causes completely unrelated to pregnancy or birth are termed When faced with an acute maternal collapse, it is helpful to think of potential causes as falling into five categories, or the 5 Hs for simplicity:4
Head including eclampsia, stroke, epilepsy, vasovagal
Heart including myocardial infarction, arrhythmia, cardiomyopathy, thoracic aortic dissection
Hypoxia including pulmonary embolus, pulmonary oedema, anaphylaxis, asthma
Haemorrhage including abruption, uterine atony, genital tract trauma, uterine rupture, uterine inversion, ruptured aortic aneurysm
wHole body and Hazards amniotic fluid embolus, hypoglycaemia, trauma, anaesthetic complications, drug reactions (illicit or prescribed), sepsis
The likelihood of any one of these being causative will obviously depend somewhat on the timing of the collapse – early or late pregnancy, intrapartum, immediately postpartum, remotely postpartum.
Maternal cardiac arrest represents a small subset of women affected by maternal collapse. The incidence is approximately 1 in 30,000 ongoing pregnancies, with a high likelihood of death for both the mother and the fetus. The vast majority of us will never need to attend a maternal cardiac arrest, and doing so is uniquely stressful. For these reasons, it is important to have a framework in mind of how to deal with a maternal cardiac arrest, and to have practised the response to this situation.
incidental deaths, and are not included in calculation of the MMR.
• Several other risk factors for maternal death are recognised. These include:
• Maternal age 35 and older
• Obesity
• Lower socioeconomic status
• Pre-existing mental health issues, substance use and domestic violence, all of which may be exacerbated by pregnancy and the puerperium
• Medical co-morbidities, particularly asthma, autoimmune diseases, inflammatory and atopic disorders, haematological disorders, essential hypertension, infections and musculoskeletal disorders
One of the important developments in improving identification of a pregnant or postnatal patient at risk of collapse during hospital admission has been the development of maternity-specific Early Warning Charts.
New ESC guideline on cardiovascular disease in pregnancyArunSharma10
New ESC Guideline on Cardiovascular Disease in Pregnancy
Management of Cardiovascular Diseases During Pregnancy
Women with CVD
LMWH
Drugs during pregnancy and breastfeeding
Valvular heart disease
Coronary artery disease
Pregnancy is complicated by maternal disease in 1–4% of cases
Venous thromboembolism is a major cause of maternal mortality. Pregnancy increases the risk of deep vein thrombosis due to physiological changes that cause venous stasis and a hypercoagulable state. The risk is highest in the antenatal period and after cesarean delivery. Diagnosis involves Doppler ultrasound or CT scan and treatment involves low molecular weight heparin for at least 6 weeks. Prevention through thromboprophylaxis is recommended for women with prior VTE or thrombophilia.
This document discusses cardiac diseases in pregnancy. It begins with the epidemiology and classification of heart diseases. It then covers the normal cardiovascular alterations in pregnancy, the effects of pregnancy on heart diseases and vice versa. It provides details on diagnosing and managing heart diseases in pregnancy, including specific cardiac conditions and complications like arrhythmias and heart failure. Close monitoring is needed during pregnancy for women with cardiac issues due to risks of maternal mortality, preterm delivery, fetal growth problems, and congenital heart defects in the baby.
- Decompression of the abdominal compartment by
opening the abdomen and leaving it open with a
temporary abdominal closure device.
- Aggressive fluid resuscitation should be avoided to prevent dilutional coagulopathy and increased intra-abdominal pressures. Early administration of platelets and fresh frozen plasma in a 1:1:1 ratio with packed red blood cells can help achieve hemostasis earlier.
- Cesarean hysterectomy is usually required for placenta accreta, though in select stable cases a conservative approach retaining the placenta may be attempted with strict follow up given high morbidity.
Rivaroxaban is contraindicated in breastfeeding women. The other options - fondaparinux, LMWH, daltaparin and warfarin - can be used during breastfeeding.
This document outlines plans for an Obstetrical Intensive Care Program with the goals of:
1) Providing comprehensive critical care expertise for obstetric patients through a dedicated program.
2) Serving as a model for critical care of obstetric patients in the Midwest region.
3) Ensuring optimal outcomes for mothers, fetuses, and newborns through collaboration between obstetric, neonatal, and critical care teams.
The program would admit patients requiring intensive monitoring and treatment for conditions such as preeclampsia, postpartum hemorrhage, heart disease, infections, and multi-organ dysfunction. It aims to improve outcomes over traditional ICUs through staff trained in obstetric critical
Cardiac disease is a leading cause of maternal mortality. During pregnancy, the cardiac output increases by 40% which can worsen existing heart conditions like rheumatic heart disease. Rheumatic heart disease, caused by untreated streptococcal infections, accounts for 90% of heart conditions in pregnancy. It often involves mitral stenosis which carries risks of heart failure, infection, blood clots and fetal loss. Pregnancy also poses risks for other heart conditions like congenital heart defects. Care involves a multidisciplinary approach with cardiologists, focusing on monitoring, preventing fluid overload and arrhythmias, and optimizing delivery for high risk mothers.
A 37-year-old woman presented at 28 weeks gestation with severe shortness of breath due to moderate to severe mitral stenosis. She had a history of rheumatic fever and a previous cesarean delivery. Her symptoms improved with heart rate control medication. She underwent a planned cesarean section under regional anesthesia with cardiopulmonary support available. Post-operatively, she recovered well and later underwent mitral valve repair to treat her mitral stenosis.
Cardiac disease is a leading cause of maternal mortality. During pregnancy, the cardiac output increases by 40% which can worsen existing heart conditions like rheumatic heart disease. Rheumatic heart disease, caused by untreated streptococcal infections, accounts for 90% of heart conditions in pregnancy. It often involves mitral stenosis which carries risks of heart failure, infection, blood clots and fetal loss. Pregnancy also poses risks for other heart conditions like congenital heart defects. Care involves a multidisciplinary approach with cardiologists, focusing on monitoring, limiting activity and weight gain, avoiding anemia and fluid overload to reduce stress on the heart. Vaginal delivery is preferred when possible but C-sections may be needed
This document discusses heart disease in pregnancy. It notes that rheumatic valvular heart disease is the most common cause of cardiovascular disease in pregnancy in developing countries. The most common rheumatic lesion is mitral stenosis. Congenital heart disease is the most frequent cardiovascular disease present during pregnancy in industrialized countries, with shunt lesions being predominant. Pregnancy can exacerbate pre-existing heart conditions and lead to complications like heart failure, arrhythmias, and pulmonary edema due to the increased cardiovascular demands. Careful management and monitoring during pregnancy and delivery are important for women with heart disease.
Hypertensive disorders in pregnancy are classified into four main categories: gestational hypertension, preeclampsia, chronic hypertension, and chronic hypertension with superimposed preeclampsia. Preeclampsia is defined as new onset hypertension and proteinuria after 20 weeks of gestation. It is caused by abnormal placentation leading to maternal endothelial dysfunction and is a leading cause of maternal and fetal morbidity and mortality. Risk factors include obesity, family history, and chronic hypertension. Treatment involves frequent monitoring, antihypertensive medications like labetalol, methyldopa, and nifedipine, and delivery if condition worsens or reaches term.
This document discusses heart disease in pregnancy. It notes that 0.4-5.0% of pregnant women have heart disease, which is a leading cause of maternal mortality. The most common heart disorders seen in pregnancy are rheumatic valve disease, congenital heart disease, and cardiomyopathy. Physiological changes in pregnancy like increased blood volume, cardiac output, and heart rate are described. Guidelines for assessing risk, managing specific conditions, determining delivery timing/location, and optimizing outcomes for mothers and babies with heart disease are provided. The importance of pre-conception counseling and a multidisciplinary approach to care is emphasized.
This document discusses cardiac disease in pregnancy. The major causes of cardiac death over the last 10 years are cardiomyopathy, myocardial infarction, and ischemic heart disease. Physiological adaptations to pregnancy include increases in blood volume, stroke volume, heart rate, and cardiac output. Labor further increases cardiac output. Examination may reveal murmurs. Echocardiography is the preferred investigation. Risks are assessed based on factors like pulmonary hypertension and cardiac function. Management involves a multidisciplinary team and monitoring for decompensation. Risks vary for different cardiac lesions and are managed accordingly, such as with endocarditis prophylaxis.
The document discusses various types of heart diseases that can occur during pregnancy including rheumatic heart disease and congenital heart disease. It notes that the two main types of rheumatic heart disease are mitral stenosis and rheumatic fever. Mitral stenosis is the most common, affecting 90% of cases. Congenital heart diseases discussed include atrial septal defects, ventricular septal defects, and patent ductus arteriosus. Complications related to heart disease in pregnancy and their treatment are summarized. Maternal and fetal risks are also categorized as low, moderate, or high risk.
Cardiovascular diseases during pregnancy, european guidlines 2011Basem Enany
This document discusses cardiac signs, symptoms, and management during pregnancy. Some normal signs include palpitations, edema, and dizziness due to increased blood volume and heart rate. Abnormal signs like anasarca and syncope require evaluation. Testing like echocardiograms are generally safe in pregnancy but radiation exposure should be minimized. Conditions like pulmonary hypertension carry high risks, while repaired defects usually pose little risk. Medical management of valvular issues and heart failure aims to support volume and avoid hypotension.
This document discusses the cardiovascular changes that occur during pregnancy and how they impact women with underlying heart disease. It notes that the incidence of heart disease complicating pregnancy is approximately 1% globally. The most common types seen in India are rheumatic heart disease (78%) and congenital heart disease (18.7%). The document outlines the normal anatomical and physiological changes pregnancy has on the cardiovascular system. It then discusses how certain heart conditions are classified based on their risk during pregnancy, from WHO class 1 (lowest risk) to WHO class 4 (highest risk). The document provides guidance on evaluating and managing women with heart disease throughout their pregnancy.
The document discusses HELLP syndrome, which is characterized by hemolysis, elevated liver enzymes, and low platelet count. It is considered by some to be a variant of preeclampsia, but may be a separate entity. HELLP syndrome has a maternal mortality rate of 2-24% and perinatal mortality of 9-39%. Diagnosis requires meeting laboratory criteria of hemolysis, elevated liver enzymes, and low platelet count. Management includes corticosteroids, magnesium sulfate, antihypertensive drugs, blood products, and delivery. Complications include disseminated intravascular coagulation, liver and kidney failure, and infant growth restriction and respiratory distress.
Peripartum cardiomyopathy is a form of heart failure that develops in the final month of pregnancy or within 5 months after delivery. It is defined as left ventricular systolic dysfunction without other identifiable causes. Risk factors include age over 30, multiparity, African descent, cocaine use, long term tocolytic therapy, multiple gestation, preeclampsia history, and nutritional deficiencies. Diagnosis involves excluding other causes by EKG, echocardiogram, labs, and symptoms matching criteria. Treatment is similar to other heart failures with diuretics, beta-blockers, digoxin, and anticoagulants considering pregnancy risk classifications. Prognosis shows 50-60% recovery within 6 months but high
Pregnancy places an additional burden on the heart due to significant hemodynamic changes. The incidence of heart disease during pregnancy has increased due to more women with congenital heart disease surviving to reproductive age. Hemodynamic changes during pregnancy and labor like increased blood volume, heart rate and cardiac output can exaggerate the symptoms of heart conditions. Close monitoring and management of heart conditions and risks is needed before, during and after pregnancy to support a healthy pregnancy outcome.
Maternal collapse during pregnancy and puerperiumDoc Nadia
The document discusses maternal collapse during pregnancy and postpartum. It defines maternal collapse and identifies women at risk. Common causes include hemorrhage, thromboembolism, amniotic fluid embolism, cardiac disease, sepsis, and other medical conditions. The initial management of maternal collapse follows resuscitation guidelines, securing the airway, providing oxygen, performing chest compressions if needed, and administering IV fluids and medications. If collapse occurs after 20 weeks gestation and there is no response to 4 minutes of CPR, perimortem cesarean delivery should be performed within 5 minutes to help maternal resuscitation efforts.
Maternal collapse by dr alka mukherjee &; dr apurva mukherjeealka mukherjee
Not all maternal deaths are preceded by an identifiable collapse, and not all maternal collapses result in death. Maternal collapse occurs any time during pregnancy, up to 42 days following delivery and is an acute event involving cardiorespiratory systems and/or brain, resulting in impaired consciousness or death.1
Maternal deaths are generally quantified as a maternal mortality ratio (MMR), expressed as the number of maternal deaths per 100,000 women giving birth. It includes deaths that occur due to complications of the pregnancy (direct deaths), and those resulting from worsening of other disease processes due to the pregnancy (indirect deaths). Deaths that occur from causes completely unrelated to pregnancy or birth are termed When faced with an acute maternal collapse, it is helpful to think of potential causes as falling into five categories, or the 5 Hs for simplicity:4
Head including eclampsia, stroke, epilepsy, vasovagal
Heart including myocardial infarction, arrhythmia, cardiomyopathy, thoracic aortic dissection
Hypoxia including pulmonary embolus, pulmonary oedema, anaphylaxis, asthma
Haemorrhage including abruption, uterine atony, genital tract trauma, uterine rupture, uterine inversion, ruptured aortic aneurysm
wHole body and Hazards amniotic fluid embolus, hypoglycaemia, trauma, anaesthetic complications, drug reactions (illicit or prescribed), sepsis
The likelihood of any one of these being causative will obviously depend somewhat on the timing of the collapse – early or late pregnancy, intrapartum, immediately postpartum, remotely postpartum.
Maternal cardiac arrest represents a small subset of women affected by maternal collapse. The incidence is approximately 1 in 30,000 ongoing pregnancies, with a high likelihood of death for both the mother and the fetus. The vast majority of us will never need to attend a maternal cardiac arrest, and doing so is uniquely stressful. For these reasons, it is important to have a framework in mind of how to deal with a maternal cardiac arrest, and to have practised the response to this situation.
incidental deaths, and are not included in calculation of the MMR.
• Several other risk factors for maternal death are recognised. These include:
• Maternal age 35 and older
• Obesity
• Lower socioeconomic status
• Pre-existing mental health issues, substance use and domestic violence, all of which may be exacerbated by pregnancy and the puerperium
• Medical co-morbidities, particularly asthma, autoimmune diseases, inflammatory and atopic disorders, haematological disorders, essential hypertension, infections and musculoskeletal disorders
One of the important developments in improving identification of a pregnant or postnatal patient at risk of collapse during hospital admission has been the development of maternity-specific Early Warning Charts.
New ESC guideline on cardiovascular disease in pregnancyArunSharma10
New ESC Guideline on Cardiovascular Disease in Pregnancy
Management of Cardiovascular Diseases During Pregnancy
Women with CVD
LMWH
Drugs during pregnancy and breastfeeding
Valvular heart disease
Coronary artery disease
Pregnancy is complicated by maternal disease in 1–4% of cases
Venous thromboembolism is a major cause of maternal mortality. Pregnancy increases the risk of deep vein thrombosis due to physiological changes that cause venous stasis and a hypercoagulable state. The risk is highest in the antenatal period and after cesarean delivery. Diagnosis involves Doppler ultrasound or CT scan and treatment involves low molecular weight heparin for at least 6 weeks. Prevention through thromboprophylaxis is recommended for women with prior VTE or thrombophilia.
This document discusses cardiac diseases in pregnancy. It begins with the epidemiology and classification of heart diseases. It then covers the normal cardiovascular alterations in pregnancy, the effects of pregnancy on heart diseases and vice versa. It provides details on diagnosing and managing heart diseases in pregnancy, including specific cardiac conditions and complications like arrhythmias and heart failure. Close monitoring is needed during pregnancy for women with cardiac issues due to risks of maternal mortality, preterm delivery, fetal growth problems, and congenital heart defects in the baby.
- Decompression of the abdominal compartment by
opening the abdomen and leaving it open with a
temporary abdominal closure device.
- Aggressive fluid resuscitation should be avoided to prevent dilutional coagulopathy and increased intra-abdominal pressures. Early administration of platelets and fresh frozen plasma in a 1:1:1 ratio with packed red blood cells can help achieve hemostasis earlier.
- Cesarean hysterectomy is usually required for placenta accreta, though in select stable cases a conservative approach retaining the placenta may be attempted with strict follow up given high morbidity.
Rivaroxaban is contraindicated in breastfeeding women. The other options - fondaparinux, LMWH, daltaparin and warfarin - can be used during breastfeeding.
This document outlines plans for an Obstetrical Intensive Care Program with the goals of:
1) Providing comprehensive critical care expertise for obstetric patients through a dedicated program.
2) Serving as a model for critical care of obstetric patients in the Midwest region.
3) Ensuring optimal outcomes for mothers, fetuses, and newborns through collaboration between obstetric, neonatal, and critical care teams.
The program would admit patients requiring intensive monitoring and treatment for conditions such as preeclampsia, postpartum hemorrhage, heart disease, infections, and multi-organ dysfunction. It aims to improve outcomes over traditional ICUs through staff trained in obstetric critical
Cardiac disease is a leading cause of maternal mortality. During pregnancy, the cardiac output increases by 40% which can worsen existing heart conditions like rheumatic heart disease. Rheumatic heart disease, caused by untreated streptococcal infections, accounts for 90% of heart conditions in pregnancy. It often involves mitral stenosis which carries risks of heart failure, infection, blood clots and fetal loss. Pregnancy also poses risks for other heart conditions like congenital heart defects. Care involves a multidisciplinary approach with cardiologists, focusing on monitoring, preventing fluid overload and arrhythmias, and optimizing delivery for high risk mothers.
A 37-year-old woman presented at 28 weeks gestation with severe shortness of breath due to moderate to severe mitral stenosis. She had a history of rheumatic fever and a previous cesarean delivery. Her symptoms improved with heart rate control medication. She underwent a planned cesarean section under regional anesthesia with cardiopulmonary support available. Post-operatively, she recovered well and later underwent mitral valve repair to treat her mitral stenosis.
Cardiac disease during pregnancy can include preexisting heart conditions or those that develop during pregnancy. It is important for pregnant women with cardiac disease to receive specialized care to prevent complications for both mother and baby, such as heart failure, preterm birth, or low birth weight. Management involves monitoring the mother closely, limiting activity and weight gain, preventing infection, and addressing any signs of decompensation through medical or surgical treatment tailored to the individual's condition and needs.
This document discusses cardiac disease in pregnancy. Key points include:
- Cardiac disease complicates 0.5-1% of pregnancies and is most often rheumatic or congenital in origin.
- Physiological changes in pregnancy like increased blood volume place additional strain on the heart.
- Evaluation of cardiac disease includes assessing symptoms, functional classification, investigations, and fetal risks.
- Management involves pre-conception counseling, monitoring during pregnancy, and planning for delivery and postpartum care depending on the severity of disease. Complications like heart failure, arrhythmias, and thromboembolism require specific treatment approaches.
This document discusses the care of pregnant clients with preexisting or newly acquired cardiac diseases or diabetes. It covers the classification and management of common heart conditions like ventricular septal defect and tetralogy of Fallot during antepartum, intrapartum, and postpartum periods. Risks of heart failure, preterm labor, growth restriction, and abortion are outlined. Principles of managing cardiac diseases in pregnancy through monitoring, rest, infection prevention and emotional stress reduction are also provided. The pathophysiology and assessment of diabetes mellitus during pregnancy and its implications on the mother and fetus are reviewed.
The clinical features in a normal pregnancy that can mimic cardiac disease include dyspnea, pedal edema, a diffused and laterally-shifted cardiac impulse, and elevated jugular veins. Systolic ejection murmurs along the left sternal border occur in 96% of pregnant women. Cardiac disease during pregnancy is diagnosed by the presence of diastolic murmurs, systolic murmurs of severe intensity, or unequivocal heart enlargement on x-ray. Termination of pregnancy is indicated before 12 weeks for conditions like Eisenmenger's syndrome, Marfan's syndrome with aortic involvement, and pulmonary hypertension due to high maternal risk. Warfarin use in the first trimester can cause fetal embry
This lecture discusses nursing management of heart disease in pregnant women. It begins by defining the classification of heart disease from Grade I to IV based on physical limitation. It then discusses hemodynamic changes during pregnancy, effects on the mother and fetus, and nursing care during the antenatal, intrapartal and postpartum periods. Specific nursing interventions are provided for higher grade heart diseases, including digitalis therapy and reducing physical exertion during delivery. The importance of monitoring for complications, supportive care and health teaching are also summarized.
This document discusses polyhydramnios, which is excess amniotic fluid in pregnancy. It defines the amniotic fluid index (AFI) and single deepest pocket measurements used to diagnose polyhydramnios. Causes discussed include fetal anomalies, twin-to-twin transfusion syndrome, diabetes, and idiopathic causes. Complications of polyhydramnios for both mother and fetus are outlined. Management approaches depending on severity are provided, including observation, amnioinfusion, or induction of labor.
Impaired to physiological chnages in pregnancy in preexisting medical disorderNurul Azlan
1. Pregnancy causes significant cardiovascular changes including increased cardiac output, decreased systemic vascular resistance, and a hypercoagulable state.
2. Respiratory changes include decreased lung volumes due to the gravid uterus pushing up the diaphragm and increased minute ventilation and oxygen consumption due to hormonal effects.
3. Common medical conditions affected by pregnancy include asthma, heart disease, diabetes, and thyroid disorders. Proper management involves multidisciplinary care and treatment of underlying conditions while minimizing risk to the mother and fetus.
This document discusses the management of heart disease during pregnancy. It notes that while pregnancy outcomes are generally favorable for women with heart disease, they remain at risk for complications like heart failure, arrhythmia, and stroke. The document outlines the normal cardiovascular changes during pregnancy, physical exam findings, diagnosis of heart conditions, and management of specific diseases like mitral stenosis, aortic stenosis, and mitral valve prolapse. It emphasizes the importance of a multidisciplinary team, monitoring for risk factors, admitting high-risk patients, administering antibiotics during labor, and managing cardiac failure. The goal is early detection and prevention of complications to optimize outcomes for both mother and baby.
Intraventricular hemorrhage (IVH) originates from blood vessels in the germinal matrix of premature infants. It can occur within 3 days (early) or after 3 days (late) of birth. The risk is inversely related to gestational age and birth weight, with up to 30% of infants under 1500g developing IVH. IVH is graded based on the extent of bleeding. It can cause complications like posthemorrhagic hydrocephalus. Treatment focuses on managing complications; serial imaging monitors for hydrocephalus requiring ventricular shunting. Neurodevelopmental outcomes worsen with higher IVH grades.
Eclampsia is a condition characterized by new onset seizures in pregnant or postpartum women complicated by severe pre-eclampsia. It is caused by an imbalance in prostaglandins leading to placental vasoconstriction and reduced perfusion. Risk factors include primigravidity, age, past medical history, and pre-existing conditions. Treatment involves arresting seizures, delivering the baby to terminate the pregnancy, and preventing complications through supportive care, monitoring, and administration of magnesium sulfate and antihypertensives. Prognosis depends on factors like time to treatment, number of seizures, and development of complications. Timely management can help reduce high maternal and fetal mortality rates associated with this condition.
Heart disease occurs in approximately 1% of pregnancies and can be caused by rheumatic heart disease, congenital heart defects, or other conditions like ischemic heart disease. Diagnosis involves taking a medical history and performing a physical exam, chest X-ray, electrocardiogram, and echocardiogram. Pregnancy places additional strain on the heart and can exacerbate existing heart conditions or lead to heart failure. Management involves rest, diet, infection prevention, hospitalization if decompensation occurs, and possibly medical treatments like diuretics, beta blockers, or surgical treatments such as cardiac surgery or therapeutic abortion in severe cases. During labor, vaginal delivery is preferred if possible but induction is not recommended if acute heart
Approach to maternal collapse and cardiac arrest.pptxKTD Priyadarshani
This is a case based discussion on approach to maternal collapse and cardiac arrest. It includes a detailed account on ERC ALS guideline on maternal cardiac arrest and post resuscitation care.
This document summarizes cardiac diseases in pregnancy. It discusses how heart diseases complicate over 1% of pregnancies and are a leading cause of indirect maternal death. Normal cardiac changes in pregnancy include increases in cardiac output, blood volume, and venous pressure. Women with cardiovascular diseases should receive pre-pregnancy counseling. During pregnancy, signs of heart disease include dyspnea, edema, murmurs, and arrhythmias. Major forms of heart disease discussed are rheumatic, congenital, and cardiomyopathy. Management involves early diagnosis, optimizing care between obstetric and cardiac teams, and ensuring hospital delivery. Labor and delivery management aims to await spontaneous labor and uses regional anesthesia, antibiotics, and active management of the third stage
Asthma is a common respiratory disease in pregnancy, affecting 3-12% of pregnant women. The severity of asthma during pregnancy varies, with 1/3 of cases worsening and 1/3 improving. Exacerbations are more likely in women with severe asthma, often occurring in the 24-36 week period. Adequate management can decrease maternal and fetal morbidity. Medications for asthma should be continued throughout pregnancy and labor, with regional anesthesia preferred over general anesthesia during delivery.
The document describes a case of a 14 month old boy presenting with cyanosis of the nails, lips and fast labored breathing on exertion. A history of difficulty feeding since birth and recurrent respiratory infections is noted. On examination, cyanosis is present and a systolic murmur is heard. Previous echocardiograms showed ventricular septal defect initially and later tetralogy of Fallot. The patient has now been referred for corrective cardiac surgery. Tetralogy of Fallot is characterized by four anatomical abnormalities and causes decreased pulmonary blood flow and cyanosis. Management involves medical therapy, palliative shunt surgery or corrective open heart surgery.
This document discusses key causes of maternal mortality in India due to preexisting and pregnancy-related medical conditions. It notes that a fifth of worldwide maternal deaths occur in India, with the most common direct causes being hemorrhage, hypertension, and sepsis. However, data also shows a significant percentage (16-48%) of maternal deaths are due to indirect medical causes like cardiac, hepatic, and infectious disorders. The document then examines specific conditions in more depth, including valvular heart diseases, cardiomyopathy, hepatitis, and issues with anticoagulation in pregnancy. It provides details on evaluating and managing women with these underlying medical disorders throughout their pregnancy.
Introduction to Assisted reproductive technology.pptxAhmed Mowafy
Infertility is defined as the failure to achieve a clinical pregnancy after 12 months of regular unprotected intercourse. It affects approximately 9-15% of reproductive-aged couples worldwide. The main causes of infertility include female factors like PCOS, endometriosis, and tubal damage; male factors like low sperm count or quality; and unexplained infertility. Treatments for infertility include ovulation induction, intrauterine insemination, in vitro fertilization, and others. Religious views on assisted reproduction vary between religions, with some being more accepting than others.
Preeclampsia is a pregnancy complication characterized by new onset hypertension and either proteinuria or other maternal organ dysfunction after 20 weeks of gestation. The cause is believed to involve abnormal placentation leading to placental ischemia and release of anti-angiogenic factors, causing widespread maternal endothelial dysfunction. Women with preeclampsia are monitored closely and delivery is often indicated if maternal or fetal complications develop. Management may involve expectant monitoring, antihypertensive treatment, and delivery depending on gestational age and severity of features.
Update management of postpartum haemorrhage.pdfAhmed Mowafy
Postpartum hemorrhage (PPH) is a leading cause of maternal mortality worldwide, responsible for over 80,000 deaths in 2015. PPH can be primary (within 24 hours of delivery) or secondary (within 12 weeks) and is classified by blood loss volume. The causes of PPH are commonly referred to as the "four Ts": tone (uterine atony), trauma, tissue (retained placenta), and thrombin (coagulopathies). Early recognition through monitoring vital signs and blood loss estimation is important. Treatment involves resuscitation, hemostatic measures like uterotonics to address the underlying cause, and consideration of surgical interventions if conservative options fail.
The document discusses luteinizing hormone (LH) structure and function, as well as its role in assisted reproduction. It summarizes evidence from multiple publications on using recombinant human LH (r-LH) as an adjuvant to recombinant FSH (r-FSH) in ovarian stimulation. The evidence is conflicting, but there is consensus that r-LH may benefit women with hypogonadotropic hypogonadism, those aged 35-39, those with a suboptimal response to r-FSH, and in reducing ovarian hyperstimulation syndrome risk. However, the optimal dose, timing and patient groups require more clarification.
Assessment and preparation of infertile couples before icsiAhmed Mowafy
This document provides information about infertility, its causes and treatments. It defines infertility as the failure to achieve pregnancy after 12 months of regular unprotected sex. It discusses infertility as a disability according to the WHO. It also defines terms like subfertility, assisted reproductive technology (ART), in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI) and their procedures. The document discusses the evaluation process for infertility including history, examination, ovarian reserve testing and semen analysis. It provides details about the IVF/ICSI cycle steps and frequently asked questions about success rates, costs, bed rest after embryo transfer and religious aspects.
This document defines infertility and its causes. It discusses male and female factors of infertility in detail. For male factors, it covers pre-testicular, testicular, and post-testicular causes and evaluates male factor infertility through history, examination, semen analysis, and assessment of sperm function. For female factors, it discusses ovarian causes of anovulation including physiological and pathological causes. It also describes the treatment of ovulatory disorders, focusing on clomiphene citrate as a first-line induction of ovulation treatment.
The Diagnostic Value of Saline Infusion Sonohysterography Versus Hysteroscopy...Ahmed Mowafy
This study evaluated the diagnostic value of saline infusion sonohysterography (SIS) compared to hysteroscopy for detecting uterine abnormalities in 161 women with infertility or recurrent pregnancy loss. SIS had slightly lower sensitivity and specificity than hysteroscopy, particularly for detecting intrauterine adhesions and congenital anomalies. However, SIS has advantages of being non-invasive, cheaper, faster, and more comfortable for patients compared to hysteroscopy. While hysteroscopy remains the gold standard, SIS is an effective initial screening tool for evaluating the uterine cavity.
In vitro fertilization and embryo transfer "IVF"; Overview on the Story FRO...Ahmed Mowafy
The document discusses the history and development of in vitro fertilization (IVF). It mentions:
- Aldous Huxley predicted IVF techniques in his 1931 novel "Brave New World".
- The first reported pregnancies from IVF occurred in the late 1950s and early 1960s involving animals.
- The first reported human pregnancy from IVF was in 1973, though it resulted in miscarriage.
- The first successful human birth from IVF, Louise Brown, occurred in 1978 in the UK from the work of Steptoe and Edwards.
HELLP syndrome is a severe form of preeclampsia characterized by hemolysis, elevated liver enzymes, and low platelets. It occurs in 0.5-0.9% of pregnancies and is diagnosed based on evidence of hemolysis, elevated liver enzymes, and low platelet count. Management of HELLP syndrome depends on disease severity and gestational age, ranging from termination of pregnancy for severe cases to conservative management including blood pressure control, magnesium sulfate to prevent seizures, and corticosteroids to improve platelet and liver function for mild to moderate cases before 34 weeks gestation.
Antiphospholipid antibody syndrome is a condition characterized by the presence of antibodies that cause an increased risk of blood clots, pregnancy complications such as miscarriage, and preeclampsia. These antibodies interfere with prostacyclin and thromboxane, leading to vasoconstriction and thrombosis. Diagnosis requires at least one clinical criteria of vascular events, pregnancy morbidity, or autoimmune disease plus a positive test for antiphospholipid antibodies. Management involves pre-conception counseling, low-dose aspirin, anticoagulation with heparin, prevention and monitoring of complications during pregnancy, and postpartum care including continued anticoagulation.
The Diagnostic value of saline infusion sonohysterography and hysteroscopy in...Ahmed Mowafy
Hysteroscopy is more sensitive and has a higher negative predictive value than saline infusion sonohysterography (SIS) in detecting intracavitary abnormalities, according to a study comparing the two techniques. The study of 80 women found hysteroscopy had a sensitivity of 96.3% versus 89.3% for SIS. Hysteroscopy also had a higher negative predictive value of 92.3% compared to 76.9% for SIS. However, SIS has advantages of being non-invasive, cheaper, faster, and less discomfortable for patients. Both techniques had few complications, with bleeding being most common for SIS. The study concludes hysteroscopy is superior for diagnosis but S
Venous thromboembolism during pregnancyAhmed Mowafy
Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, can occur during pregnancy. The risk of VTE is highest during the antepartum period and with cesarean delivery. Risk factors include prior VTE, thrombophilia, older age, obesity, multiparity, bed rest, and certain medical conditions. Treatment involves anticoagulants like heparin and warfarin, with heparin preferred in early pregnancy due to risks of warfarin exposure to the fetus. Patients are classified as very high, high, moderate, or low risk, with treatment strategies varying based on risk level.
Cardiotocography monitors the fetal heartbeat and uterine contractions during pregnancy and labor. It involves measuring the fetal heart rate, uterine contractions, fetal movement and heart rate accelerations. Abnormal findings include bradycardia, tachycardia, minimal heart rate variability, and late decelerations which can indicate fetal distress requiring interventions like oxygen supplementation or emergency delivery. The NST and CST (oxytocin challenge test) are used to assess fetal wellbeing by observing fetal heart rate patterns in response to movement or induced contractions.
Single port laparoscopic hysterectomy is a new minimally invasive surgical technique that uses only one small incision in the belly button to remove the uterus through the vagina, compared to traditional laparoscopic hysterectomy which uses multiple small incisions. This new technique aims to reduce pain, scarring and recovery time for patients undergoing hysterectomy.
retract the wound edges laterally using self-retaining
retractors to expose the peritoneal cavity
Operative Techniques
IV.Abdominal wall incision
Sub-umblical vertical midline incision
Disadvantages:
1. Poor cosmetic results
2. Higher incidence of incisional hernia
3. Limited exposure of adnexae
4. More pain in the postoperative period
5. Difficult to close the incision in obese patients
So Pfannenstiel incision is preferred in elective cases and midline
incision in emergency cases or when good exposure is needed.
The choice depends on the obstetrician preference and the
clinical situation.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
3. • Most pregnant women develop fatigue , shortness of breath, exercise
capacity , palpitations .
• Some times peripheral edema , jagular venous distension ,audible
physiologic 3rd heart sound , audible systolic flow murmer .
• This is explained by : changes occurring during 1st 5 -8 weeks of pregnancy
and reach the peak by the end of 2nd trimester . These changes include :
4. 1. Changes in blood volume
by 40 – 50 % during pregnancy and reach the peak at 32nd week remained
at high level to delivery occur .
2. Changes in cardiac output
by 30 – 50 % above normal level and reach the peak by 20th – 24th week of
pregnancy after which a plateau till delivery occurs . these changes in cardiac
output occurs due to :
i. preload due to blood volume
ii. afterload due to systemic vascular resistance
iii. heart rate
3. Changes in heart rate
heart rate by 10 – 15 b/min
5. 4. Changes in blood pressure
remains normal however systolic and diastolic blood pressure may in the
2nd trimester but becomes normal again in the 3rd trimester
systolic by 5 – 10 mm/Hg
diastolic by 10 – 15 mm/Hg
Due to vasodilatation caused by :
i. Prostacyclin and hormones of pregnancy
ii. Placenta acts as arterio – venous shunt thus peripheral resistance .
5. Changes in blood chemistry
• Fibrinogen by 50 % , in factors 7 , 8 , 9 ,10 , platelets remains normal .
• RBCs , WBCs ( up to 12,000/mm3 is normal )
• in blood urea , serum creatinine , nitrogen and uric acid
6. Heart displacement
In late pregnancy , the apex is displaced upward and outward to be in the 4th
intercostals space outside the mid-clavicular line .
6. 7. Liability to varicose vein
This occurs due to :
i. Pressure of gravid uterus on pelvic veins .
ii. Relaxation of smooth muscle fibers in the blood vessel wall by
progesterone .
iii. in the blood volume .
Supine hypotensive Syndrome :
In late pregnancy when woman lies in supine position fainting attack
Why ? heavy gravid uterus compresses IVC leading to :
i. Poor venous return .
ii. Poor cardiac output .
iii. Low blood pressure .
7. 1-4 % , the most common non-obstetric cause of maternal mortality
Varies in countries :
Developing countries :
rheumatic heart diseases are the most common ( mitral stenosis is the most
common )
Developed countries :
congenital heart diseases ( ASD – VSD – PDA )
• Ischemic heart disease : rare but now due to :
i. use of COCs
ii. smoking
iii. Older age of pregnancy
iv. DM
8. Grade I :
Asymptomatic , no limitation of activity
Grade II :
Symptoms ( Dyspnea , palpitation , anginal pain ) on ordinary work
Grade III :
Symptoms with less than ordinary work but comfortable at rest
Grade IV :
Symptoms at rest with evidence of congestive heart failure
9. Pregnancy deteriorates the patient one clinical grade
1. Heart failure :
i. between 28th – 32nd week maximum in blood volume , cardiac
output and heamodilution (anaemic heart failure )
ii. During labour contraction load on heart ( in 2nd stage of labour
more than 1st stage) , stress and anxiety
iii. 3rd stage of labour or immediately postpartum :
• after placental delivery 500 – 900 ml of blood passed to general
circulation load on heart
• sudden release of pressure on IVC cardiac output is doubled
• acute pulmonary edema with maternal mortality 70 %
10. 2. Cardiac arrhythmias threshold for arrhythmias ( atrial fibrillation
especially with mitral stenosis )
3. Reactivation of rheumatic activity
4. Subacute bacterial endocarditis especially during peurperium
5. Postpartum thromboembolic complications especially with caesarian
section ( 5 – 7 day postpartum ) pelvic thromophlebitis
6. Pulmonary embolism up to 7th day postpartum
11. Fetal complications :
i. Abortion
ii. IUGR
iii. IUFD
iv. Preterm labour
v. CFMF
vi. Early neonatal death
Maternal complications :
i. Polyhydraminos ( part of systemic venous congestion )
ii. Preterm labour ( cervix is congested )
iii. Postpartum hemorrhage
12. SCREENING
Any pregnant female should be examined at least once for heart
( EVEN IF SHE IS ASYMPTOMATIC )
Symptoms suggesting heart disease with pregnancy :
i. Dyspnea
ii. Palpitation
iii. Warm extremities
iv. Lower limb edema
v. Intolerance to exertion
vi. Syncopal attack
vii. Plethoric face
viii. Sinus tachycardia
ANY PATIENT WITH DYSPNEA AS A COMPLAINT MUST BE TAKEN SERIOUSLY
13. ONCE THESE SYMPTOMS DISCOVERED
Sure signs of heart disease with pregnancy ( by a cardiologist ) :
i. Diastolic murmer and opening snap
ii. Systolic murmer and if > grade III palpable thrill
iii. Accentuated 1st heart sound , fixed paradoxic split of 2nd heart sound
iv. Diastolic gallop
v. Pericardial rub
vi. cardiomegally
Investigations :
i. Electrocardiogram ECG
ii. Chest radiography
iii. Echocardiography
14. Before conception : ( pre-conception counseling )
Reassurance of the patient about maternal and fetal risk during pregnancy,
suitable method for contraception , maternal morbidity and mortality
Women with NYHA class III , class IV are liable to :
i. Maternal mortality up to 7 %
ii. Maternal morbidity up to 30 %
So they should be strongly cautioned against pregnancy
15. After conception : ( management of pregnant woman with a
cardiac disease )
Antenatal care ANC : should be in a special clinic under supervision of both
obstetrician and cardiologist . medical treatment depend on the NYHA class
of the patient .
NYHA class I , class II ( compensated patient ) :
1. ANC : every 2 weeks and hospitalized between 28th , 32nd weeks
2. Rest : more time of rest mental and physical – more time of sleep 2 hours
in the afternoon and 8 hours at night
3. Diet : as any normal pregnancy proteins , carbohydrates , fat , salt
free diet and avoid weight gain
4. Drugs :
guard against
i. heart failure by treatment of anaemia if present ( patient Hb must be not
less than 11 gm/dL ) iron + folic acid + calcium
ii. infections long acting penicillin , dental care prophylaxis of SABE
iii. arrhythmia proper sedation
iv. thromboembolic disorders give anti-coagulant when needed
16. NYHA class III , class VI ( decompensated patient ) :
A) if < 12 weeks
1. Termination of pregnancy
HOW ?
Before 12 weeks and never after 12 weeks because the risk of termination
> risk of continuation by Suction under heavy sedation
2. Cardiac surgery
Closed cardiac surgery Open cardiac surgery
Mitral valvotomy can be done Mitral or aortic valve replacement
between 20 – 24 weeks 1) Heterograft
2) Metallic valve
3) Human graft
Little risk on mother Great fetal risk not preferred
Slight risk on fetus
17. OTHER INDICATIONS OF TERMINATION OF PREGNANCY : ( < 12 weeks when
cardiac surgery is not possible )
i. Esinmenger's syndrome 40 % mortality rate and pulmonary
hypertension due to any cause .
ii. Heart failure in previous pregnancy or before this pregnancy .
iii. History of rheumatic activity or subacute bacterial endocarditic in the
last 2 years .
iv. History of atrial fibrillation .
b) if > 12 weeks Hospitalization
1. Hospitalization through the whole time of pregnancy +
bed rest in semi-sitting position
2. Diet : as any normal pregnancy proteins ,
carbohydrates , fat , salt free diet and avoid
weight gain
3. Drugs : the same as grade I , II + maintained anti-failure treatment ( digitalis
+ diuretics + potassium + aminophylline + O2 inhalation )
18. Route of Delivery :
1. Vaginal delivery : usually easy and rapid due to :
i. Small baby
ii. Cervical congestion
2. Caesarean section :
i. obstetric indications
ii. in patients with severe mitral stenosis , aortic stenosis ,
pulmonary hypertension and Esinmenger's some advice
elective caesarean section to avoid contraction and straining
( controverse )
19. Intra partum management :
Managed by ( Obstetrician + Cardiologist + ICU specialist )
A) During 1st stage of labour :
i. Rest in semi-sitting position to aid respiration
ii. Oxygen inhalation
iii. Analgesia : the best epidural anesthesia or pethidine to avoid
tachycardia resulting from labour pain
iv. Concentrated glucose as a nutrient
v. Start antibiotic therapy combination of ampicillin 2 gm + gentamycin
1.5 mg / kg IV or IM and repeated after 8 hours ( vancomycin in case of
ampicillin sensitivity )
20. B) During 2nd stage of labour :
i. Put the patient in semi-sitting position
ii. Oxygen inhalation in between contractions
iii. Analgesia maintain epidural anesthesia
iv. No bearing down , no straining to avoid rising in blood pressure
v. If 2nd stage is prolonged more than 20 minutes ( forceps – ventose )
21. C) During 3rd stage of labour :
There should be no hurry , Time should be allowed for post partum circulatory
adjustment .
i. Oxytocin is given to all patient unless there is a heart failure
ii. Ergometrine is avoided unless there is severe bleeding ( The risks of atonic
postpartum haemorrhage must be balanced against the risk ergometrine )
iii. Misopristol in case of severe bleeding ( relative contra-indication )
iv. Lactation is allowed in NYHA class I , II and suppressed in NYHA class III , VI
v. Close observation for at least two hours
vi. Continue antibiotic therapy
Puerperium :
i. Hospitalization one week for NYHA class I , II and 3 weeks for NYHA III , IV
ii. Prophylaxis against subacute bacterial endocarditis by ampicilline +
gentamycin
iii. Sedation in the 1st few days after labour to reduce tachycardia
If the patient developed a heart failure , she is not allowed to get pregnant
22. Management of post-partum acute pulmonary edema :
If the patient quickly developed
• Dyspnea
• Frothy sputum
• Haemoptysis
We should quickly do the following
1. Proppe the patient up
2. if possible, the legs allowed to hang over the edge of the bed
3. Morphine (5-15 mg) may be given intra-muscularly
4. frusemide (20-40 mg) given intravenously
5. Venous return can be reduced by applying inflatable cuffs to the limbs
6. Quickly call ICU specialist for further management
23. Safe During Breast-
Drug Use Side Effects Safety in Pregnancy
feeding
Oligohydramnios,
IUGR, PDA,
prematurity,
neonatal
ACE inhibitors Hypertension No Yes
hypotension, renal
failure, anemia,
musculoskeletal
abnormalities
Hypertension, Fetal bradycardia,
arrhythmias, MI, low birth weight,
Beta-blockers Yes Yes
hyperthyroidism, hypoglycemia,
cardiomyopathy respiratory
depression
Low birth weight,
Digoxin Arrhythmia, CHF Yes Yes
prematurity
Fetal distress with
Nitrates Hypertension Yes No data
maternal
hypotension
24. Safe During Breast-
Drug Use Side Effects Safety in Pregnancy
feeding
Reduced
Diuretics Hypertension, CHF Unknown
uteroplacental Yes
perfusion
Arrhythmia, Neonatal CNS
Lidocaine Yes Yes
anesthesia depression
Hypercoagulable states, Hemorrhage, bone
LMWH Limited Limited data
DVT, mechanical valves, density
atrial fibrillation
Warfarin
Hypercoagulable
embryopathy,
states, DVT, No Yes
Warfarin fetal CNS
mechanical valves,
abnormalities,
atrial fibrillation
hemorrhage
Hypercoagulable Maternal
Unfractionated states, DVT, osteoporosis,
Yes Yes
heparin mechanical valves, hemorrhage,
atrial fibrillation thrombocytopenia
, thrombosis
Sodium Hypertension, aortic Fetal thiocyanate
No No data
nitroprusside dissection toxicity
25. 1. Preterm labour in a cardiac patient ( very common )
B-mimetic are contra-indicated
2. Pregnancy-induced hypertension in a cardiac patient
Never use magnesium sulphate and depend only on diazepam
2. Anesthesia in a cardiac patient
• For all vaginal delivery the best is epidural anesthesia , pudendal nerve
block and sedation
• For C.S epidural anesthesia , careful
general anesthesia and local infiltration
anesthesia
26. Overall maternal mortality rate :
• NYHA class I , II 0.4 %
• NYHA class III , IV 7 %
Factors affecting prognosis :
i. Nature of cardiac disease : very high risk with mitral or aortic stenosis
ii. Clinical Class of the patient , her age and parity
iii. Social factors , degree of antenatal care , socio-economic conditions and
ability of the patient to get bed rest
iv. Presence of other bad signs ; cardiomegally . SABE and rheumatic
activity